eMedevents
  • 135382+ Medical Conferences
  • 251 Specialties
  • 10409 Organizers
  • 150724 Speakers
  • 155 Countries
  • 4521 Cities
45127+
CME Conference Registrations Sold
Home  >  Speakers  >  Naiyer A. Rizvi
Naiyer A. Rizvi

Naiyer A. Rizvi

    MD
Director, Professor | New York, New York    United States of America
Oncology, Haematology
Oncology, Hematology,...More
Spoken at 7 events
Speaking at 2 events

Biography :

Dr. Rizvi is the director of thoracic oncology and director of immunotherapeutics for the division of Hematology and Oncology at Columbia University Medical Center. He also holds the Price Chair in Clinical Translational Research.

He is an internationally recognized leader in the treatment of lung cancer and immunotherapy drug development. Prior to joining Columbia University Medical Center, his clinical research at Memorial Sloan Kettering Cancer played a significant role in the FDA approval path of a new class of immunotherapies, called immune checkpoint inhibitors, for melanoma and lung cancer.

His research focus is studying mechanisms of sensitivity and resistance to immunotherapy. Through genetic testing of tumors, he has been able to improve the understanding of why immune checkpoint inhibitors work in certain patients. This work has been partially supported by Stand Up To Cancer -- Cancer Research Institute Immunology funding.

**********************
***** ********* ***** ********
This section has yet to be updated by the speaker.
For speaker's contact information - Contact us

Specialties

Oncology, Haematology

Interested Topics

Oncology, Hematology, Lung Cancer, Thoracic Cancer, Esophageal Cancer, Thymic Cancer, Mesothelioma, Immunotherapy, Cancer, Thoracic Oncology, Medical Oncology, Cancer Care

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
Close

Send Message